An annual general meeting (“AGM”) in iCoat Medical AB (publ), corp. reg. no 559172-8208 (the “Company”) was held on 15 June 2022 in Stockholm. All decisions were made in accordance with the proposals presented in the notice of the AGM.

 

Adoption of the income statement and the balance sheet: allocation of result

The AGM adopted the income statement and balance sheet for the Company in accordance with submitted accounting documents. The annual general meeting further resolved to allocate the Company’s result in accordance with the board’s proposal, i.e. that the Company’s result is carried forward in its entirety. The resolution means that no dividend is paid for the financial year 2021.

 

Discharge from liability

The AGM resolved to discharge the board members and the CEO from liability for the financial year 2021.

 

Resolution on remuneration to the board and auditor

The AGM resolved, in accordance with the nomination committee’s proposal, on board remuneration with the following allocation: SEK 200,000 to the chairman and SEK 100,000 to each of the other board members.

Further, the AGM resolved, in accordance with the nomination committee’s proposal, that the auditor shall be paid the approved invoice.

 

Election of board members and auditor

The AGM resolved to re-elect Hans Larsson, Carl Bjartmar, Marianne Jensen Waern, Bo Nilsson, Bertil Villard and Martin Åmark as members of the Board of Directors. Hans Larsson was re-elected as Chairman.

The AGM resolved to elect KPMG AB as the Company’s auditor, with Per Hammar as the auditor in charge.

 

Resolution regarding nomination committee and guidelines for the work of the nomination committee

The AGM resolved to re-elect Kristina Nilsson Ekdahl, Johan Thorell, Pär Josefsson, Marianne Jensen Waern and Hans Larsson as members of the nomination committee.

Further, the nomination committee’s proposal to adopt instructions for the work of the nomination committee was approved by the AGM.

 

Amendment of the Articles of Association

The AGM resolved to amend one article in the Articles of Association to reflect that the Company’s registered office is changed from Uppsala to Stockholm.

 

All resolutions at the AGM were adopted unanimously.

 

————————————

iCoat Medical AB (publ)

The board of directors

 

For more information, please contact:

Peder Waern, CEO, iCoat Medical AB

E-mail: peder.waern@icoatmedical.com 

 

Mattias Springare, CFO, iCoat Medical AB
E-mail: mattias.springare@icoatmedical.com